Revision history of "Modulation of dendritic cell activity for therapeutic vaccination against hepatocarcinoma" (Q3199775)

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

11 October 2024

  • curprev 09:5709:57, 11 October 2024DG Regio talk contribs 78,932 bytes +5 Changed label, description and/or aliases in pt
  • curprev 09:5609:56, 11 October 2024DG Regio talk contribs 78,927 bytes −51 Set a claim value: summary (P836): O hepatocarcinoma (HCC) é um tumor cada vez mais frequente, para o qual há poucas opções terapêuticas. As vacinas antitumoral à base de células dendríticas (DC) são uma ferramenta promissora no tratamento do CHC, no entanto, a sua eficácia clínica tem sido limitada. No decurso de um ensaio de vacinação de CD em pacientes com hepatite C, a principal causa de HCC no nosso ambiente, descobrimos que factores imunomoduladores, tais como Interleucina 10,...

20 March 2024

20 December 2023

12 June 2023

10 June 2023

18 August 2022

  • curprev 09:3409:34, 18 August 2022DG Regio talk contribs 77,705 bytes +53,698 Changed label, description and/or aliases in el, da, fi, mt, lv, sk, ga, cs, pt, et, hu, bg, lt, hr, sv, ro, sl, pl, nl, fr, de, it, es, and other parts: Adding translations: el, da, fi, mt, lv, sk, ga, cs, pt, et, hu, bg, lt, hr, sv, ro, sl, pl,

16 January 2022

17 December 2021

9 December 2021

4 December 2021

13 October 2021

  • curprev 00:0500:05, 13 October 2021DG Regio talk contribs 12,765 bytes +2,425 Created claim: summary (P836): Hepatocarcinoma (HCC) is an increasingly frequent tumor, for which there are few therapeutic options. Dendritic cell-based (CD) antitumour vaccines are a promising tool in the treatment of HCC, however their clinical efficacy has been limited. In the course of a CD vaccination trial in patients with hepatitis C, the main cause of HCC in our environment, we have found that immunomodulatory factors, such as Interleukin 10, affect their immunostimu...
  • curprev 00:0500:05, 13 October 2021DG Regio talk contribs 10,340 bytes −2,425 Removed claim: summary (P836): Hepatocarcinoma (HCC) is an increasingly frequent tumor, for which there are few therapeutic options. Dendritic cell-based (CD) antitumour vaccines are a promising tool in the treatment of HCC, however their clinical efficacy has been limited. In the course of a CD vaccination trial in patients with hepatitis C, the main cause of HCC in our environment, we have found that immunomodulatory factors, such as Interleukin 10, affect their immunosti...

12 October 2021

  • curprev 23:2623:26, 12 October 2021DG Regio talk contribs 12,765 bytes +148 Changed label, description and/or aliases in en: translated_label
  • curprev 23:2623:26, 12 October 2021DG Regio talk contribs 12,617 bytes +2,425 Created claim: summary (P836): Hepatocarcinoma (HCC) is an increasingly frequent tumor, for which there are few therapeutic options. Dendritic cell-based (CD) antitumour vaccines are a promising tool in the treatment of HCC, however their clinical efficacy has been limited. In the course of a CD vaccination trial in patients with hepatitis C, the main cause of HCC in our environment, we have found that immunomodulatory factors, such as Interleukin 10, affect their immunostimu...

11 October 2021

10 October 2021

8 October 2021